Dyslipidemia News and Research

RSS
Dyslipidemia is a disruption in the amount of lipids in the blood.
Treatment with life-saving medications increases in IHD but levels still suboptimal

Treatment with life-saving medications increases in IHD but levels still suboptimal

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Inflammation from diets deficient in nutrients contribute to weight despite intake of macronutrients

Inflammation from diets deficient in nutrients contribute to weight despite intake of macronutrients

Resistance training can help reduce liver fat levels in patients suffering from fatty liver disease

Resistance training can help reduce liver fat levels in patients suffering from fatty liver disease

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

Wayne State researchers explore effects of Tocotrienol-rich fraction from palm oil in ESRD patients

Wayne State researchers explore effects of Tocotrienol-rich fraction from palm oil in ESRD patients

Lixiana (edoxaban) recommended for treating, preventing recurrent DVT and PE in adults

Lixiana (edoxaban) recommended for treating, preventing recurrent DVT and PE in adults

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Study: Genes may not trigger heart disease in people suffering from migraine with aura

Study: Genes may not trigger heart disease in people suffering from migraine with aura

ACT intervention may be effective in reducing risk for cardiovascular disease

ACT intervention may be effective in reducing risk for cardiovascular disease

Small intestine causes chronic inflammation in obese patients

Small intestine causes chronic inflammation in obese patients

Amgen to discuss data supporting Repatha BLA for high cholesterol treatment with FDA EMDAC

Amgen to discuss data supporting Repatha BLA for high cholesterol treatment with FDA EMDAC

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Study: Rheumatoid arthritis nearly doubles risk of surprise heart attack

Study: Rheumatoid arthritis nearly doubles risk of surprise heart attack

Study suggests link between androgens, atherosclerosis and obesity in females

Study suggests link between androgens, atherosclerosis and obesity in females

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Liraglutide may help obese adults achieve weight loss

Liraglutide may help obese adults achieve weight loss